The FDA warns that both CJC-1295 and ipamorelin are risky for immunogenicity, potentially causing life-threatening outcomes such as anaphylaxis.25 26 Cardiovascular concerns: Specifically concerning CJC-1295, the FDA warns of the risk of increased heart rate and systemic vasodilatory reaction, including flushing, warmth, and transient hypotension.25 27 Cancer: With their ability to increase the rate of cellular replication, growth hormone secretagogues in general are unsafe for cancer survivors and people with an active cancer diagnosis.28 Secretagogue use may elevate their risk for recurrence or worsen their prognosis
How should I compare NAD+ Peptide Complex with alternatives
A drug taken long-term to treat GERD was the culprit
Loss of appetite , the peptide suppressed appetite and led to mild weight loss
We are a leading primary care practice and weight loss clinic in Canton, MI
Review the peptide stacking calculator for compatibility guidance